Mark E. McGovern
EVP, Chief Medical Officer, KOS PHARMACEUTICALS INC.
Companies
- Esperion TherapeuticsBoard member Feb 20, 2014 to May 28, 20211
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREsperion Therapeutics, Board member